BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34291800)

  • 21. Visceral fat accumulation affects risk of colonic diverticular hemorrhage.
    Nagata N; Sakamoto K; Arai T; Niikura R; Shimbo T; Shinozaki M; Aoki T; Sekine K; Okubo H; Watanabe K; Sakurai T; Yokoi C; Yanase M; Akiyama J; Noda M; Uemura N
    Int J Colorectal Dis; 2015 Oct; 30(10):1399-406. PubMed ID: 26099321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenoma.
    Nagata N; Sakamoto K; Arai T; Niikura R; Shimbo T; Shinozaki M; Aoki T; Kishida Y; Sekine K; Tanaka S; Okubo H; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Noda M; Itoh T; Mizokami M; Uemura N
    Int J Cancer; 2014 Nov; 135(10):2273-81. PubMed ID: 24692064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiological biomarkers reflecting visceral fat distribution help distinguish inflammatory bowel disease subtypes: a multicenter cross-sectional study.
    Xiong Z; Wu P; Zhang Y; Chen J; Shen Y; Kamel I; Wu B; Zheng X; Li Z
    Insights Imaging; 2024 Mar; 15(1):70. PubMed ID: 38472526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic Review and Meta-Analysis: Preoperative Vedolizumab and Postoperative Complications in Patients with IBD.
    Moosvi Z; Duong JT; Bechtold ML; Nguyen DL
    South Med J; 2021 Feb; 114(2):98-105. PubMed ID: 33537791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abdominal visceral fat accumulation measured by computed tomography associated with an increased risk of gallstone disease.
    Sekine K; Nagata N; Sakamoto K; Arai T; Shimbo T; Shinozaki M; Okubo H; Watanabe K; Imbe K; Mikami S; Nozaki Y; Sakurai T; Yokoi C; Kojima Y; Kobayakawa M; Yanase M; Akiyama J; Noda M; Uemura N
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1325-31. PubMed ID: 25869941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low muscle mass at initiation of anti-TNF therapy for inflammatory bowel disease is associated with early treatment failure: a retrospective analysis.
    Holt DQ; Varma P; Strauss BJG; Rajadurai AS; Moore GT
    Eur J Clin Nutr; 2017 Jun; 71(6):773-777. PubMed ID: 28225051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.
    Fox CS; Massaro JM; Hoffmann U; Pou KM; Maurovich-Horvat P; Liu CY; Vasan RS; Murabito JM; Meigs JB; Cupples LA; D'Agostino RB; O'Donnell CJ
    Circulation; 2007 Jul; 116(1):39-48. PubMed ID: 17576866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study.
    Irlbeck T; Massaro JM; Bamberg F; O'Donnell CJ; Hoffmann U; Fox CS
    Int J Obes (Lond); 2010 Apr; 34(4):781-7. PubMed ID: 20065971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review and meta-analysis: risks of postoperative complications with preoperative use of anti-tumor necrosis factor-alpha biologics in inflammatory bowel disease patients.
    Moosvi Z; Duong J; Bechtold ML; Nguyen DL
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):799-816. PubMed ID: 33079779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal visceral adipose tissue is associated with unsuspected pulmonary embolism on routine CT scans in patients with gastrointestinal cancer.
    Xiao X; Wang Y; Gao Y; Xie Q; Zhou X; Lin L; Dekkers IA; Lamb HJ
    Br J Radiol; 2019 Dec; 92(1104):20190526. PubMed ID: 31595778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Visceral Adipose Tissue on Clinical Outcomes After Acute Ischemic Stroke.
    Kim JH; Choi KH; Kang KW; Kim JT; Choi SM; Lee SH; Park MS; Kim BC; Kim MK; Cho KH
    Stroke; 2019 Feb; 50(2):448-454. PubMed ID: 30612535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT-derived abdominal adiposity: Distributions and better predictive ability than BMI in a nationwide study of 59,429 adults in China.
    Zeng Q; Wang L; Dong S; Zha X; Ran L; Li Y; Chen S; Gao J; Li S; Lu Y; Zhang Y; Xiao X; Li Y; Ma X; Gong X; Chen W; Yang Y; Du X; Chen B; Lv Y; Wu Y; Hong G; Pan Y; Jiao J; Yan Y; Qi H; Zhai J; Li K; Zhao K; Wu J; Liu S; Blake GM; Fu H; Fu X; Guo Z; Lemieux I; Després JP; Cheng X;
    Metabolism; 2021 Feb; 115():154456. PubMed ID: 33259834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by
    Rivers JP; Powell-Wiley TM; Dey AK; Rodante JA; Chung JH; Joshi AA; Natarajan B; Sajja AP; Chaturvedi A; Rana A; Harrington CL; Teague HL; Lockshin BN; Ahlman MA; Yao J; Playford MP; Gelfand JM; Mehta NN
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):349-357. PubMed ID: 29055628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing changes in visceral adiposity is associated with higher risk for colorectal adenoma: Multilevel analysis in a prospective cohort.
    Moon JM; Im JP; Kim D; Han YM; Soh H; Song JH; Yang SY; Kim YS; Yim JY; Lim SH; Kim JS
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1836-1842. PubMed ID: 33300216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study.
    Yamamoto-Furusho JK; Al Harbi O; Armuzzi A; Chan W; Ponce de Leon E; Qian J; Shapina M; Toruner M; Tu CH; Ye BD; Guennec M; Sison C; Demuth D; Fadeeva O; Khan QMR
    Dig Liver Dis; 2020 Aug; 52(8):869-877. PubMed ID: 32563721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visceral adiposity is associated with an increased risk of functional dyspepsia.
    Jung JG; Yang JN; Lee CG; Choi SH; Kwack WG; Lee JH; Kang HW
    J Gastroenterol Hepatol; 2016 Mar; 31(3):567-74. PubMed ID: 26313910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
    Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.
    Mader O; Juillerat P; Biedermann L; Michetti P; Hruz P; Pittet V; Rogler G; Zahnd-Straumann N; Seibold F
    United European Gastroenterol J; 2021 Apr; 9(3):398-406. PubMed ID: 33203339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors.
    Reijrink M; de Boer SA; Spoor DS; Lefrandt JD; Lambers Heerspink HJ; Boellaard R; Greuter MJ; Borra RJH; Hillebrands JL; Slart RHJA; Mulder DJ
    Atherosclerosis; 2019 Nov; 290():87-93. PubMed ID: 31604171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.